168 related articles for article (PubMed ID: 29271385)
1. Anti-apoptosis Effect of Decoy Receptor 3 in Cholangiocarcinoma Cell Line TFK-1.
Xu YC; Cui J; Zhang LJ; Zhang DX; Xing BC; Huang XW; Wu JX; Liang CJ; Li GM
Chin Med J (Engl); 2018 Jan; 131(1):82-87. PubMed ID: 29271385
[TBL] [Abstract][Full Text] [Related]
2. Silencing of decoy receptor 3 (DcR3) expression by siRNA in pancreatic carcinoma cells induces Fas ligand-mediated apoptosis in vitro and in vivo.
Zhou J; Song S; He S; Wang Z; Zhang B; Li D; Zhu D
Int J Mol Med; 2013 Sep; 32(3):653-60. PubMed ID: 23846297
[TBL] [Abstract][Full Text] [Related]
3. Decoy receptor 3 expressed in rheumatoid synovial fibroblasts protects the cells against Fas-induced apoptosis.
Hayashi S; Miura Y; Nishiyama T; Mitani M; Tateishi K; Sakai Y; Hashiramoto A; Kurosaka M; Shiozawa S; Doita M
Arthritis Rheum; 2007 Apr; 56(4):1067-75. PubMed ID: 17393415
[TBL] [Abstract][Full Text] [Related]
4. Condensed tannins from Ulmus pumila L. leaves induce G2/M phase arrest and apoptosis via caspase-cascade activation in TFK-1 cholangiocarcinoma cells.
Ren Y; Qin Z; Wang Z; Wei S; Chen H; Zhu T; Liu L; Zhao Y; Ding B; Song W
J Food Biochem; 2022 Oct; 46(10):e14374. PubMed ID: 35986624
[TBL] [Abstract][Full Text] [Related]
5. The soluble Decoy Receptor 3 is regulated by a PI3K-dependent mechanism and promotes migration and invasion in renal cell carcinoma.
Weissinger D; Tagscherer KE; Macher-Göppinger S; Haferkamp A; Wagener N; Roth W
Mol Cancer; 2013 Oct; 12(1):120. PubMed ID: 24107265
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of Decoy Receptor 3 Impairs Growth and Invasiveness of Hepatocellular Carcinoma Cell Line of HepG2.
Zhou XN; Li GM; Xu YC; Zhao TJ; Wu JX
Chin Med J (Engl); 2016 Nov; 129(21):2623-2629. PubMed ID: 27779171
[TBL] [Abstract][Full Text] [Related]
7. Decoy receptor 3 expression in AsPC-1 human pancreatic adenocarcinoma cells via the phosphatidylinositol 3-kinase-, Akt-, and NF-kappa B-dependent pathway.
Chen PH; Yang CR
J Immunol; 2008 Dec; 181(12):8441-9. PubMed ID: 19050262
[TBL] [Abstract][Full Text] [Related]
8. 'Decoy' and 'non-decoy' functions of DcR3 promote malignant potential in human malignant fibrous histiocytoma cells.
Toda M; Kawamoto T; Ueha T; Kishimoto K; Hara H; Fukase N; Onishi Y; Harada R; Minoda M; Kurosaka M; Akisue T
Int J Oncol; 2013 Sep; 43(3):703-12. PubMed ID: 23817777
[TBL] [Abstract][Full Text] [Related]
9. Decoy receptor 3 suppresses FasL-induced apoptosis via ERK1/2 activation in pancreatic cancer cells.
Zhang Y; Li D; Zhao X; Song S; Zhang L; Zhu D; Wang Z; Chen X; Zhou J
Biochem Biophys Res Commun; 2015 Aug; 463(4):1144-51. PubMed ID: 26102031
[TBL] [Abstract][Full Text] [Related]
10. Decoy receptor 3 regulates the expression of various genes in rheumatoid arthritis synovial fibroblasts.
Fukuda K; Miura Y; Maeda T; Takahashi M; Hayashi S; Kurosaka M
Int J Mol Med; 2013 Oct; 32(4):910-6. PubMed ID: 23912906
[TBL] [Abstract][Full Text] [Related]
11. Upregulated LASP-1 correlates with a malignant phenotype and its potential therapeutic role in human cholangiocarcinoma.
Zhang H; Li Z; Chu B; Zhang F; Zhang Y; Ke F; Chen Y; Xu Y; Liu S; Zhao S; Liang H; Weng M; Wu X; Li M; Wu W; Quan Z; Liu Y; Zhang Y; Gong W
Tumour Biol; 2016 Jun; 37(6):8305-15. PubMed ID: 26729195
[TBL] [Abstract][Full Text] [Related]
12. Decoy receptor 3: an endogenous immunomodulator in cancer growth and inflammatory reactions.
Hsieh SL; Lin WW
J Biomed Sci; 2017 Jun; 24(1):39. PubMed ID: 28629361
[TBL] [Abstract][Full Text] [Related]
13. Decoy Receptor 3 Suppresses T-Cell Priming and Promotes Apoptosis of Effector T-Cells in Acute Cell-Mediated Rejection: The Role of Reverse Signaling.
Weng SC; Wen MC; Hsieh SL; Chen NJ; Tarng DC
Front Immunol; 2022; 13():879648. PubMed ID: 35720343
[TBL] [Abstract][Full Text] [Related]
14. DcR3 promotes hepatoma cell migration by downregulating E-cadherin expression.
Zhang H; Chen X; Li D; Cui L; Li X; Ye X; Wan X
Oncol Rep; 2017 Jul; 38(1):377-383. PubMed ID: 28560426
[TBL] [Abstract][Full Text] [Related]
15. Dcr3 inhibit p53-dependent apoptosis in gamma-irradiated lung cancer cells.
Sung HY; Wu HG; Ahn JH; Park WY
Int J Radiat Biol; 2010 Sep; 86(9):780-90. PubMed ID: 20597837
[TBL] [Abstract][Full Text] [Related]
16. [Relationship between expression of decoy receptor 3 and apoptosis in hepatocellular carcinoma].
Chen G; Luo DZ; Wang Y; Liao ZL; Zhang MY
Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):113-7. PubMed ID: 17493386
[TBL] [Abstract][Full Text] [Related]
17. Endogenous decoy receptor 3 blocks the growth inhibition signals mediated by Fas ligand in human pancreatic adenocarcinoma.
Tsuji S; Hosotani R; Yonehara S; Masui T; Tulachan SS; Nakajima S; Kobayashi H; Koizumi M; Toyoda E; Ito D; Kami K; Mori T; Fujimoto K; Doi R; Imamura M
Int J Cancer; 2003 Aug; 106(1):17-25. PubMed ID: 12794752
[TBL] [Abstract][Full Text] [Related]
18. IGFBP7 is associated to prognosis and could suppress cell survival in cholangiocarcinoma.
Yue C; Yang M; Tian Q; Mo F; Peng J; Ma Y; Huang Y; Wang D; Wang Y; Hu Z
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):817-825. PubMed ID: 29991293
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
Gene; 2019 May; 698():50-60. PubMed ID: 30822475
[TBL] [Abstract][Full Text] [Related]
20. Decoy receptor 3: a pleiotropic immunomodulator and biomarker for inflammatory diseases, autoimmune diseases and cancer.
Lin WW; Hsieh SL
Biochem Pharmacol; 2011 Apr; 81(7):838-47. PubMed ID: 21295012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
